Login   |  Users Online: 391 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts

    Article Cited by others

REVIEW ARTICLE

Medohara and Lekhaniya dravyas (anti-obesity and hypolipidemic drugs) in Ayurvedic classics: A critical review

Kumari Harshitha, Pushpan Reshmi, Nishteswar K

Year : 2013| Volume: 34| Issue : 1 | Page no: 11-16

   This article has been cited by
 
1 Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress
Sarayu A. Pai,Renuka P. Munshi,Falguni H. Panchal,Ila-Shruti Gaur,Snehal N. Mestry,Malvika S. Gursahani,Archana R. Juvekar
Biomedicine & Pharmacotherapy. 2019; 111: 686
[Pubmed]  [Google Scholar] [DOI]
2 Need for comprehensive standardization strategies for marketed Ayurveda formulations
Vishvanath Narhari Vaidya,A.U. Tatiya,Ashwini Elango,Subrahmanya Kumar Kukkupuni,Chethala N. Vishnuprasad
Journal of Ayurveda and Integrative Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Plumbagin exerts antiobesity effects through inhibition of pancreatic lipase and adipocyte differentiation
S.A. Pai,E.A.F. Martis,S.G. Joshi,R.P. Munshi,A.R. Juvekar
Phytotherapy Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Ayurvedic anti-diabetic formulation Lodhrasavam inhibits a-amylase and a-glucosidase suppresses adipogenic activity of 3T3-L1 cells
Megha Abhijit Butala,Subrahmanya Kumar Kukkupuni,Chethala N. Vishnuprasad
Journal of Ayurveda and Integrative Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article